Timothy P. Coughlin is CFO at NEUROCRINE BIOSCIENCES INC (NBIX). They have made 7 open-market trades across 2 companies since 2008, most recently 2019-05-08.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $300K since 2016, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBIX | SELL · 10b5-1 | 2017-02-06 | 2017-02-08 | $43.14 | $42K | +0.0% | +5.5% | +19.8% |
| NBIX | SELL | 2017-02-03 | 2017-02-06 | $42.55 | $128K | -0.6% | +3.2% | +19.0% |
| NBIX | SELL | 2017-01-17 | 2017-01-18 | $40.65 | $142K | -4.3% | +5.1% | +24.2% |
| NBIX | SELL | 2017-01-10 | 2017-01-12 | $43.37 | $152K | -2.6% | +2.4% | +25.8% |
| FATE | BUY | 2016-11-23 | 2016-11-28 | $2.66 | $300K | -2.6% | -12.6% | +34.8% |
| NBIX | SELL | 2016-02-03 | 2016-02-04 | $38.06 | $57K | +3.9% | -2.0% | +16.9% |
| NBIX | SELL | 2016-01-19 | 2016-01-21 | $46.69 | $163K | -22.8% | -26.2% | -7.7% |
| NBIX | SELL | 2016-01-11 | 2016-01-13 | $44.25 | $155K | +7.6% | -17.2% | +2.8% |
| NBIX | SELL · 10b5-1 | 2015-10-16 | 2015-10-19 | $47.78 | $1.2M | -24.3% | -5.3% | -16.7% |
| NBIX | SELL · 10b5-1 | 2015-07-20 | 2015-07-21 | $55.00 | $1.1M | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2015-07-13 | 2015-07-14 | $50.00 | $1.0M | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2015-06-08 | 2015-06-10 | $45.08 | $2.7M | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2015-03-20 | 2015-03-24 | $44.49 | $1.8M | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2015-01-16 | 2015-01-21 | $30.81 | $54K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2015-01-12 | 2015-01-13 | $28.37 | $50K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2015-01-08 | 2015-01-09 | $27.25 | $273K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2014-12-18 | 2014-12-19 | $23.46 | $704K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2014-12-10 | 2014-12-12 | $21.48 | $430K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2014-11-28 | 2014-12-02 | $20.14 | $201K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2014-10-31 | 2014-11-03 | $19.00 | $190K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2014-10-28 | 2014-10-30 | $18.31 | $366K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2014-01-10 | 2014-01-13 | $18.56 | $32K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2014-01-07 | 2014-01-08 | $16.75 | $1.2M | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2013-08-21 | 2013-08-22 | $15.05 | $286K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2013-08-05 | 2013-08-07 | $14.99 | $164K | -24.3% | -5.3% | -5.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.